Luye Pharma Group Ltd. (HKG:2186)
Hong Kong · Delayed Price · Currency is HKD 1.580
-0.115 (-6.78%)
Oct 22, 2026, 4:08 PM HKT
Luye Pharma Group Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, Luye Pharma Group stock has a consensus rating of "Buy" and an average price target of $2.83. The average 1-year stock price forecast is 79.11% higher than the current stock price, while the lowest is $2.33 (+47.47%) and the highest is $3.32 (+110.13%).
Price Target: $2.83 (+79.11%)
Analyst Consensus: Buy
Price Target
Chart* Price targets were last updated on Sep 4, 2026.
Analyst Ratings
The average analyst rating for Luye Pharma Group stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Apr '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst Goldman Sachs No rating | Goldman Sachs | Hold Maintains $2.67 → $2.33 | Hold | Maintains | $2.67 → $2.33 | +47.47% | Sep 4, 2026 |
Unknown Analyst SDIC Securities No rating | SDIC Securities | Buy Maintains $4.14 → $2.85 | Buy | Maintains | $4.14 → $2.85 | +80.38% | Jul 24, 2026 |
Unknown Analyst Essence Securities No rating | Essence Securities | Buy Maintains $2.85 | Buy | Maintains | $2.85 | +80.38% | Jul 24, 2026 |
Financial Forecast
Revenue This Year
6.16B
from 6.31B
Decreased by -2.34%
Revenue Next Year
6.50B
from 6.16B
Increased by 5.44%
EPS This Year
n/a
EPS Next Year
n/a
Financial currency is CNY.